FDANonrulemakingFDA-2024-N-2422

Who commented on this docket

Amending Over-the-Counter Monograph M013: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use

1 organizations filed 1 public comment on Amending Over-the-Counter Monograph M013: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use, at the Food and Drug Administration. The comment window closed 669d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 669d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.